Condensed Consolidated Statements of Redeemable Convertible Preferred Stock and Stockholders’ Equity (Deficit) - USD ($) $ in Thousands		Total	Redeemable Convertible Preferred Stock	Common Stock	Additional Paid-In Capital	Accumulated Other Comprehensive Income (Loss)	Accumulated Deficit
Temporary equity, beginning balance (in shares) at Jan. 31, 2021	[1]		182,934,257
Temporary equity, beginning balance at Jan. 31, 2021			$ 615,697
Increase (Decrease) in Temporary Equity [Roll Forward]
Conversion of redeemable convertible preferred stock into common stock in connection with the reverse recapitalization, including impact of Series H-1 paid in kind dividend (in shares)	[1]		182,934,257
Conversion of redeemable convertible preferred stock into common stock in connection with the reverse recapitalization, including impact of Series H-1 paid in kind dividend			$ 615,697
Temporary equity, ending balance (in shares) at Apr. 30, 2021	[1]		0
Temporary equity, ending balance at Apr. 30, 2021			$ 0
Beginning balance (in shares) at Jan. 31, 2021	[1]			22,961,032
Beginning balance at Jan. 31, 2021		$ (616,521)		$ 2	$ 62,736	$ 155	$ (679,414)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Conversion of redeemable convertible preferred stock into common stock in connection with the reverse recapitalization, including impact of Series H-1 paid in kind dividend (in shares)	[1]			194,060,336
Conversion of redeemable convertible preferred stock into common stock in connection with the reverse recapitalization, including impact of Series H-1 paid in kind dividend		615,697		$ 20	615,677
Reclassification of Legacy ChargePoint preferred stock warrant liability upon the reserve capitalization		66,606			66,606
Issuance of common stock upon the reverse recapitalization, net of issuance costs (in shares)	[1]			60,746,989
Issuance of common stock upon the reverse recapitalization, net of issuance costs		200,466		$ 6	200,460
Issuance of common stock upon exercise of warrants (in shares)	[1]			9,766,774
Issuance of common stock upon exercise of warrants		225,376		$ 1	225,375
Contingent earnout liability recognized upon the closing of the reverse recapitalization		(828,180)			(828,180)
Issuance of earnout shares upon triggering events, net of tax withholding (in shares)	[1]			17,539,657
Issuance of earnout shares upon triggering events, net of tax withholding		488,305		$ 2	488,303
Reclassification of remaining contingent earn-out liability upon triggering event		242,640			242,640
Vesting of early exercised stock options		78			78
Repurchase of unvested restricted shares (in shares)	[1]			(1,588)
Stock-based compensation		7,577			7,577
Net loss		82,289					82,289
Other comprehensive income (loss)		7				7
Ending balance (in shares) at Apr. 30, 2021	[1]			305,073,200
Ending balance at Apr. 30, 2021		484,340		$ 31	1,081,272	162	(597,125)
Temporary equity, beginning balance (in shares) at Jan. 31, 2021	[1]		182,934,257
Temporary equity, beginning balance at Jan. 31, 2021			$ 615,697
Temporary equity, ending balance (in shares) at Oct. 31, 2021	[1]		0
Temporary equity, ending balance at Oct. 31, 2021			$ 0
Beginning balance (in shares) at Jan. 31, 2021	[1]			22,961,032
Beginning balance at Jan. 31, 2021		(616,521)		$ 2	62,736	155	(679,414)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net loss		(72,092)
Other comprehensive income (loss)		(531)
Ending balance (in shares) at Oct. 31, 2021	[1]			330,987,173
Ending balance at Oct. 31, 2021		585,399		$ 33	1,337,247	(376)	(751,505)
Temporary equity, beginning balance (in shares) at Apr. 30, 2021	[1]		0
Temporary equity, beginning balance at Apr. 30, 2021			$ 0
Temporary equity, ending balance (in shares) at Jul. 31, 2021	[1]		0
Temporary equity, ending balance at Jul. 31, 2021			$ 0
Beginning balance (in shares) at Apr. 30, 2021	[1]			305,073,200
Beginning balance at Apr. 30, 2021		484,340		$ 31	1,081,272	162	(597,125)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of common stock upon exercise of warrants (in shares)	[1]			4,378,568
Issuance of common stock upon exercise of warrants		113,608		$ 0	113,608
Issuance of common stock upon exercise of vested stock options (in shares)	[1]			3,292,219
Issuance of common stock upon exercise of vested stock options		1,761			1,761
Issuance of earnout shares upon triggering events, net of tax withholding (in shares)	[1]			8,773,596
Issuance of earnout shares upon triggering events, net of tax withholding		(8,080)		$ 1	(8,081)
Vesting of early exercised stock options		40			40
Issuance of common stock upon release of restricted stock units (in shares)	[1]			652,901
Stock-based compensation		28,293			28,293
Net loss		(84,938)					(84,938)
Other comprehensive income (loss)		(12)				(12)
Ending balance (in shares) at Jul. 31, 2021	[1]			322,170,484
Ending balance at Jul. 31, 2021		535,012		$ 32	1,216,893	150	(682,063)
Temporary equity, ending balance (in shares) at Oct. 31, 2021	[1]		0
Temporary equity, ending balance at Oct. 31, 2021			$ 0
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of common stock under stock plans, net of tax withholding (in shares)	[1]			1,741,713
Issuance of common stock under stock plans, net of tax withholding		976			976
Issuance of common stock upon exercise of warrants (in shares)	[1]			1,379,800
Issuance of common stock upon exercise of warrants		1,264			1,264
Issuance of common stock pursuant to business combinations (in shares)	[1]			5,695,176
Issuance of common stock upon ESPP purchase		102,058		$ 1	102,057
Vesting of early exercised stock options		35			35
Stock-based compensation		16,022			16,022
Net loss		(69,442)					(69,442)
Other comprehensive income (loss)		(526)				(526)
Ending balance (in shares) at Oct. 31, 2021	[1]			330,987,173
Ending balance at Oct. 31, 2021		585,399		$ 33	1,337,247	(376)	(751,505)
Beginning balance (in shares) at Jan. 31, 2022				334,760,615
Beginning balance at Jan. 31, 2022		547,014		$ 33	1,366,855	(8,219)	(811,655)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of common stock under stock plans, net of tax withholding (in shares)				1,631,104
Issuance of common stock under stock plans, net of tax withholding		773		$ 1	772
Issuance of common stock upon exercise of warrants (in shares)				16,948
Issuance of common stock upon exercise of warrants		48			48
Issuance of common stock upon ESPP purchase (in shares)				263,962
Issuance of common stock upon ESPP purchase		3,920			3,920
Vesting of early exercised stock options		17			17
Stock-based compensation		15,527			15,527
Net loss		(89,266)					(89,266)
Other comprehensive income (loss)		(12,941)				(12,941)
Ending balance (in shares) at Apr. 30, 2022				336,672,629
Ending balance at Apr. 30, 2022		465,092		$ 34	1,387,139	(21,160)	(900,921)
Beginning balance (in shares) at Jan. 31, 2022				334,760,615
Beginning balance at Jan. 31, 2022		$ 547,014		$ 33	1,366,855	(8,219)	(811,655)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of common stock upon exercise of vested stock options (in shares)		3,061,363
Net loss		$ (266,446)
Other comprehensive income (loss)		(26,835)
Ending balance (in shares) at Oct. 31, 2022				341,531,034
Ending balance at Oct. 31, 2022		338,590		$ 34	1,451,711	(35,054)	(1,078,101)
Beginning balance (in shares) at Apr. 30, 2022				336,672,629
Beginning balance at Apr. 30, 2022		465,092		$ 34	1,387,139	(21,160)	(900,921)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of common stock under stock plans, net of tax withholding (in shares)				2,147,834
Issuance of common stock under stock plans, net of tax withholding		728			728
Vesting of early exercised stock options		15			15
Stock-based compensation		26,419			26,419
Net loss		(92,700)					(92,700)
Other comprehensive income (loss)		(7,865)				(7,865)
Ending balance (in shares) at Jul. 31, 2022				338,820,463
Ending balance at Jul. 31, 2022		391,689		$ 34	1,414,301	(29,025)	(993,621)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of common stock under stock plans, net of tax withholding (in shares)				1,435,049
Issuance of common stock under stock plans, net of tax withholding		314			314
Issuance of common stock upon exercise of warrants (in shares)				936,764
Issuance of common stock upon exercise of warrants		6,354			6,354
Issuance of common stock upon ESPP purchase (in shares)				343,422
Issuance of common stock upon ESPP purchase		5,027			5,027
Vesting of early exercised stock options		17			17
Repurchase of unvested restricted shares (in shares)				(4,664)
Stock-based compensation		25,698			25,698
Net loss		(84,480)					(84,480)
Other comprehensive income (loss)		(6,029)				(6,029)
Ending balance (in shares) at Oct. 31, 2022				341,531,034
Ending balance at Oct. 31, 2022		$ 338,590		$ 34	$ 1,451,711	$ (35,054)	$ (1,078,101)

[1] The shares of the Company’s common and redeemable convertible preferred stock prior to the Merger (as defined in Note 1) have been retroactively restated to reflect the exchange ratio of approximately 0.9966 established in the Merger as described in Note 1.